Literature DB >> 22461662

Metabolic syndrome defined by modified International Diabetes Federation criteria and type 2 diabetes mellitus risk: a 9-year follow-up among the aged in Finland.

Marika Salminen1, Marikka Kuoppamäki, Tero Vahlberg, Ismo Räihä, Kerttu Irjala, Sirkka-Liisa Kivelä.   

Abstract

The aim was to analyse the relationship between metabolic syndrome and type 2 diabetes mellitus risk among the aged. This was a prospective population-based study, with a 9-year follow-up. All subjects of the municipality of Lieto in Finland aged ≥64 in 1998-1999 with no type 2 diabetes mellitus at baseline (n=1117) were included. Hazard ratios for incident type 2 diabetes mellitus predicted by metabolic syndrome (defined by modified International Diabetes Federation criteria) were estimated. During the 9-year follow-up, a total of 69 participants (6.2%) developed type 2 diabetes mellitus. After multivariable adjustment (age, gender, smoking, frequency of exercise, cardiovascular disease and low-density lipoprotein-cholesterol), type 2 diabetes mellitus (hazard ratio, 95% confidence interval) (3.15, 1.89-5.25, p < 0.001) was more common in subjects with metabolic syndrome compared to subjects without it. Evaluating metabolic syndrome components individually, impaired fasting glucose (5.09, 2.64-9.82, p < 0.001) and obesity (1.71, 1.05-2.97, p = 0.034) predicted a higher incidence of type 2 diabetes mellitus. Our findings suggest that metabolic syndrome predicts onset of type 2 diabetes mellitus even in late life. Impaired fasting glucose and obesity should be targets for primary prevention of diabetes among the aged with metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461662     DOI: 10.1177/1479164112442077

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  4 in total

1.  Leptin expression in HIV-infected patients during antiretroviral therapy.

Authors:  Cătălin Tiliscan; Victoria Aramă; Raluca Mihăilescu; Daniela Ioana Munteanu; Adrian Streinu-Cercel; Daniela Adriana Ion; Mihaela Andreea Rădulescu; Cristina Popescu; Alina Elena Lobodan; Anca Ruxandra Negru; Ştefan Sorin Aramă
Journal:  Germs       Date:  2015-09-01

Review 2.  Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness.

Authors:  Jeong-Ah Shin; Jin-Hee Lee; Sun-Young Lim; Hee-Sung Ha; Hyuk-Sang Kwon; Yong-Moon Park; Won-Chul Lee; Moo-Il Kang; Hyeon-Woo Yim; Kun-Ho Yoon; Ho-Young Son
Journal:  J Diabetes Investig       Date:  2013-05-28       Impact factor: 4.232

3.  Prevalence of metabolic syndrome among adults with liver function injury in rural area of Southwest China: A cross-sectional study.

Authors:  Hui Zeng; Hui Lin; Wenyi Liu; Jia Wang; Lingqiao Wang; Chuanfen Zheng; Yao Tan; Yujing Huang; Lixiong He; Jiaohua Luo; Chaowen Pu; Renping Zhang; Xiaohong Yang; Yingqiao Tian; Zhiqun Qiu; Ji-An Chen; Yang Luo; Xiaobin Feng; Guosheng Xiao; Liping Wu; Weiqun Shu
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

4.  Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno-Sobetsu Study.

Authors:  Hirofumi Ohnishi; Shigeyuki Saitoh; Hiroshi Akasaka; Tetsuaki Furukawa; Mitsuru Mori; Tetsuji Miura
Journal:  Diabetol Metab Syndr       Date:  2016-09-05       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.